NM_005271.5:c.*1282G>C

Variant summary

Our verdict is Likely benign. The variant received -6 ACMG points: 0P and 6B. BP4_StrongBP6_Moderate

The NM_005271.5(GLUD1):​c.*1282G>C variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00275 in 151,544 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).

Frequency

Genomes: 𝑓 0.0027 ( 1 hom., cov: 32)
Failed GnomAD Quality Control

Consequence

GLUD1
NM_005271.5 3_prime_UTR

Scores

2

Clinical Significance

Likely benign criteria provided, single submitter B:1

Conservation

PhyloP100: 0.729

Publications

0 publications found
Variant links:
Genes affected
GLUD1 (HGNC:4335): (glutamate dehydrogenase 1) This gene encodes glutamate dehydrogenase, which is a mitochondrial matrix enzyme that catalyzes the oxidative deamination of glutamate to alpha-ketoglutarate and ammonia. This enzyme has an important role in regulating amino acid-induced insulin secretion. It is allosterically activated by ADP and inhibited by GTP and ATP. Activating mutations in this gene are a common cause of congenital hyperinsulinism. Alternative splicing of this gene results in multiple transcript variants. The related glutamate dehydrogenase 2 gene on the human X-chromosome originated from this gene via retrotransposition and encodes a soluble form of glutamate dehydrogenase. Related pseudogenes have been identified on chromosomes 10, 18 and X. [provided by RefSeq, Jan 2016]
GLUD1 Gene-Disease associations (from GenCC):
  • hyperinsulinism-hyperammonemia syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Labcorp Genetics (formerly Invitae), ClinGen, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -6 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.53).
BP6
Variant 10-87050469-C-G is Benign according to our data. Variant chr10-87050469-C-G is described in ClinVar as Likely_benign. ClinVar VariationId is 301376.Status of the report is criteria_provided_single_submitter, 1 stars.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_005271.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GLUD1
NM_005271.5
MANE Select
c.*1282G>C
3_prime_UTR
Exon 13 of 13NP_005262.1P00367-1
GLUD1
NM_001318900.1
c.*1282G>C
3_prime_UTR
Exon 13 of 13NP_001305829.1P00367-3
GLUD1
NM_001318901.1
c.*1282G>C
3_prime_UTR
Exon 16 of 16NP_001305830.1P00367-2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GLUD1
ENST00000277865.5
TSL:1 MANE Select
c.*1282G>C
3_prime_UTR
Exon 13 of 13ENSP00000277865.4P00367-1
GLUD1
ENST00000915201.1
c.*1282G>C
downstream_gene
N/AENSP00000585260.1
GLUD1
ENST00000898383.1
c.*1282G>C
downstream_gene
N/AENSP00000568442.1

Frequencies

GnomAD3 genomes
AF:
0.00275
AC:
417
AN:
151428
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000681
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00375
Gnomad ASJ
AF:
0.00576
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000208
Gnomad FIN
AF:
0.000675
Gnomad MID
AF:
0.0190
Gnomad NFE
AF:
0.00421
Gnomad OTH
AF:
0.00577
GnomAD4 exome
Data not reliable, filtered out with message: AC0
AC:
0
AN:
0
Hom.:
0
Cov.:
0
AC XY:
0
AN XY:
0
African (AFR)
AC:
0
AN:
0
American (AMR)
AC:
0
AN:
0
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AC:
0
AN:
0
South Asian (SAS)
AC:
0
AN:
0
European-Finnish (FIN)
AC:
0
AN:
0
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AC:
0
AN:
0
Other (OTH)
AC:
0
AN:
0
GnomAD4 genome
AF:
0.00275
AC:
416
AN:
151544
Hom.:
1
Cov.:
32
AF XY:
0.00259
AC XY:
192
AN XY:
74016
show subpopulations
African (AFR)
AF:
0.000679
AC:
28
AN:
41260
American (AMR)
AF:
0.00375
AC:
57
AN:
15202
Ashkenazi Jewish (ASJ)
AF:
0.00576
AC:
20
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5162
South Asian (SAS)
AF:
0.000208
AC:
1
AN:
4814
European-Finnish (FIN)
AF:
0.000675
AC:
7
AN:
10376
Middle Eastern (MID)
AF:
0.0170
AC:
5
AN:
294
European-Non Finnish (NFE)
AF:
0.00421
AC:
286
AN:
67954
Other (OTH)
AF:
0.00571
AC:
12
AN:
2102
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
22
44
67
89
111
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00259
Hom.:
0
Bravo
AF:
0.00278
Asia WGS
AF:
0.000866
AC:
3
AN:
3478

ClinVar

ClinVar submissions
Significance:Likely benign
Revision:criteria provided, single submitter
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
Hyperinsulinism-hyperammonemia syndrome (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.53
CADD
Benign
8.7
DANN
Benign
0.52
PhyloP100
0.73

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs181931207; hg19: chr10-88810226; API